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The associations of types of fish and fish preparation methods with pancreatic cancer risk remain unknown.
The authors conducted a prospective cohort study in western Washington State among 66,616 adults, aged 50–
76 years, who participated in the VITamins And Lifestyle cohort study. Diet was assessed by a food frequency
questionnaire. Pancreatic cancer cases were identified by linkage to the Surveillance, Epidemiology, and End
Results cancer registry. During an average follow-up of 6.8 years, 151 participants developed pancreatic cancer
(adenocarcinoma). Long-chain (n-3) polyunsaturated fatty acids (LC-PUFAs) and nonfried fish intake were in-
versely associated with pancreatic cancer incidence. When the highest and lowest tertiles of exposure were
compared, the multivariable-adjusted hazard ratio of pancreatic cancer was 0.62 (95% confidence interval: 0.40,
0.98) (Ptrend = 0.08) for LC-PUFAs and 0.55 (95% confidence interval: 0.34, 0.88) (Ptrend = 0.045) for nonfried
fish. Docosahexaenoic acid showed a greater inverse association with pancreatic cancer than eicosapentaenoic
acid. No statistically significant associations were observed with fried fish and shellfish consumption. The poten-
tial health impact of fish consumption may depend on the types of fish consumed and fish preparation methods.
LC-PUFAs, particularly docosahexaenoic acid, and nonfried fish, but not shellfish or fried fish, may be beneficial
in the primary prevention of pancreatic cancer.
cohort study; pancreatic cancer; preparation method; type of fish
Abbreviations: CI, confidence interval; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid;
LC-PUFA, long-chain (n-3) polyunsaturated fatty acid; NSAID, nonsteroidal antiinflammatory drug; SEER, Surveillance, Epide-
miology, and End Results; VITAL, VITamins And Lifestyle.
Because of the poor prognosis and short survival period,
it is extremely important to identify factors that may lead to
prevention of pancreatic cancer (1). Extensive research
efforts have provided us with insight into the role of diet, a
modifiable exposure, in the development of pancreatic
cancer (2). Various dietary factors have been investigated
as potential predictors of this disease. Particularly, long-
chain (n-3) polyunsaturated fatty acids (LC-PUFAs)
abundant in fish, including eicosapentaenoic acid (EPA,
20:5n-3), docosapentaenoic acid (DPA, 22:5n-3), and
docosahexaenoic acid (DHA, 22:6n-3), were hypothesized
to be beneficial against pancreatic cancer because of the
antiinflammatory properties of these nutrients (3), and
chronic inflammation may play a role in pancreatic carcino-
genesis (4, 5). However, the associations between fish or
LC-PUFA intake and risk of pancreatic cancer remain
unclear. To date, 7 cohort studies examined fish consump-
tion in relation to incidence or mortality of pancreatic
cancer (6–12). None found a statistically significant associ-
ation between fish intake and pancreatic cancer risk. The
pooled relative risk for pancreatic cancer was 0.98 (95%
confidence interval (CI): 0.86, 1.12) when comparing the
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highest with the lowest category of total fish consumption
(13). Of note, all prior cohort studies focused on total fish
rather than type of fish or preparation methods (e.g., fried
vs. nonfried fish). Because frying, especially deep frying,
may substantially reduce LC-PUFA content (14) and gener-
ate unexpected chemicals such as heterocyclic amines and
benzo(a)pyrene (15) that may promote pancreatic carcino-
genesis (16, 17), combining fried and nonfried fish may at-
tenuate or mask any possible association between fish
consumption and pancreatic cancer. Therefore, we prospec-
tively examined different types of fish consumption and
LC-PUFA intake in relation to pancreatic cancer incidence
in the VITamins And Lifestyle (VITAL) cohort study,
which has detailed information on fish consumption and
comprehensive assessment of LC-PUFA exposures, includ-
ing dietary and supplemental sources.
MATERIALS AND METHODS
Study population and design
The VITAL cohort was established in 2000–2002, with
the primary aim to investigate associations of dietary sup-
plement use with cancer risk. Details of the study design
and methods have been described elsewhere (18). Briefly,
participants were men and women aged 50–76 years at
entry, living in a 13-county area covered by the Seattle-
Puget Sound Surveillance, Epidemiology, and End Results
(SEER) cancer registry, who completed a 24-page baseline
questionnaire. A total of 364,418 baseline questionnaires
were mailed, followed by a postcard reminder after 2
weeks. Of these, 77,719 were returned and deemed eligible
(18, 19). For the present study, we excluded participants
with a positive (n = 49) or missing (n = 213) history of pan-
creatic cancer at baseline. We also excluded those who had
missing data on family history of pancreatic cancer
(n = 922), education (n = 1,284), alcohol consumption
(n = 1,215), and height and weight (n = 2,565). In addition,
participants were excluded from the nutrient and food anal-
ysis if they did not complete all pages of the food frequen-
cy section (at least 5 items per page), if their total calorie
intake was below 800 kcal for men or 600 kcal for women,
or their calorie intake was above 5,000 kcal for men or
above 4,000 kcal for women (n = 4,847). Moreover, 8 cases
of pancreatic neuroendocrine tumors that occurred during
follow-up were excluded because the biology of this tumor
is different from that of pancreatic adenocarcinoma. After
these exclusions, 66,616 participants remained in the
analysis.
All participants gave informed consent. The study design
and data analyses were approved by the institutional review
boards of the University of North Carolina at Chapel Hill
and the Fred Hutchinson Cancer Research Center.
Diet assessment
In the VITAL cohort study, data were self-reported by
using a 24-page gender-specific, optically scanned ques-
tionnaire that covered 3 content areas: supplement use, diet,
and health history and risk factors (18).
Diet was assessed by using a 120-item food frequency
questionnaire that included adjustment questions on types of
foods and preparation techniques. The food frequency ques-
tionnaire was adapted from the one used in the Women’s
Health Initiative and other studies (20–22). Participants
were asked about their usual frequency of intake of 120
foods and beverages over the past year. The medium
serving size for each food or food group was gender specific
and given as a reference, and participants were asked to in-
dicate the amount of food consumption as small, medium,
or large for adjustment of nutrient data. Fish intake was
measured on the basis of questions ascertaining the frequen-
cy of consumption of the following: 1) fried fish, fish sand-
wiches, and fried shellfish (e.g., shrimp and oysters); 2)
shellfish, not fried (e.g., shrimp, lobster, crab, and oysters);
3) white fish (broiled or baked) (e.g., sole, halibut, and cod);
4) dark fish (broiled or baked) (e.g., salmon and fresh tuna);
and 5) canned tuna, tuna salad, and tuna casserole. Because
frying may generate unexpected chemicals related to pancre-
atic carcinogenesis (16, 17) and shellfish likely contain
some carcinogenetic toxins (23), we classified fish con-
sumption into 3 groups in the analyses: 1) fried fish (includ-
ing fried fish and fish sandwiches and fried shellfish); 2)
nonfried fish; and 3) shellfish (not fried). Nutrient values
including LC-PUFAs were computed by using the Minneso-
ta Nutrient Data System based on the frequencies of con-
sumption of each food and portion size (24). Participants
were also asked to report the number of days per week for
how many years of use of fish oil supplements during the
10 years prior to baseline. Total LC-PUFA intake was calcu-
lated from both dietary and supplemental sources.
The overall measurement properties of the food frequen-
cy questionnaire were evaluated previously (22, 25). The
Pearson correlation coefficients between the food frequency
questionnaire and 8 days of dietary recalls and food records
were 0.63 for saturated fat, 0.64 for monounsaturated fat,
and 0.54 for polyunsaturated fat (22). However, the correla-
tion coefficient for LC-PUFAs was not reported in the eval-
uation studies. Also, the measurements for types of fish and
fish preparation have not been specifically evaluated.
Outcome identification
Participants were followed for pancreatic cancers occur-
ring from baseline through 2008, by linking the cohort to
the Seattle-Puget Sound SEER registry. Registry cases were
captured through all hospitals in the area; through offices of
pathologists, oncologists, and radiotherapists; and from
state death certificates. Pancreatic cancer cases were identi-
fied in the cohort by using matching algorithms on personal
identifiers and human review (18). In this study, pancreatic
cancer referred to adenocarcinoma and neuroendocrine
tumors. All incident cases of pancreatic adenocarcinoma
were defined on the basis of International Classification of
Diseases for Oncology, Third Edition (ICD-O-3), codes
C250–C259, C25.0–C25.3, or C25.7–C25.9. We excluded
endocrine pancreatic tumors (C25.4) in the analyses
because the etiology of these cancers is thought to be dif-
ferent. For each participant, the person-time was calculated
depending on the earliest date of the following events:
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0.06 (0.03) 0.20 (0.05) 0.56 (0.32) 0.27 (0.28)
EPA 0.02 (0.01) 0.06 (0.02) 0.20 (0.14) 0.09 (0.11)
DHA 0.04 (0.02) 0.12 (0.03) 0.32 (0.19) 0.16 (0.16)
Age, years 61.9 (7.5) 61.6 (7.4) 61.6 (7.2) 61.7 (7.4)
Body mass indexc 27.5 (5.5) 27.5 (5.2) 27.3 (4.8) 27.4 (5.2)
Female 62.6 52.0 36.9 50.5




25.8 17.6 12.8 18.7
Some college 41.6 38.1 34.1 37.9
College or
advanced degree
32.6 44.3 53.1 43.3
Physical activity, MET
hours/week
4.0 (0.7–11.6) 5.9 (1.4–15.0) 8.8 (2.6–19.6) 6.1 (1.3–15.5)
Smoking status
Never 47.7 47.6 47.0 47.5
Former (quit >10
years)
33.4 37.3 40.2 37.0
Former (quit ≤10
years)
8.3 7.3 6.6 7.4
Current 10.6 7.8 6.2 8.2
Alcohol consumption,
g/day
0.7 (0.0–5.8) 2.0 (0.0–10.6) 4.2 (0.1–13.9) 1.6 (0.0–10.6)




2.8 3.1 2.9 2.9




0.64 (0.42) 1.25 (0.71) 2.52 (1.69) 1.47 (1.34)
Shellfish,
servings/week
0.16 (0.13) 0.29 (0.29) 0.51 (0.68) 0.32 (0.46)
Fried fish,
servings/week
0.18 (0.15) 0.34 (0.32) 0.60 (0.82) 0.37 (0.54)
Fruit, servings/day 1.4 (1.3) 1.7 (1.4) 2.0 (1.5) 1.7 (1.4)
Vegetables,
servings/day
































withdrawal from the study (0.3%); death (6.8%); emigration
out of the SEER catchment area (5.4%); or December 31,
2008 (87.5%), the last date of linkage to the SEER registry.
Deaths were ascertained by linkage to the Washington
State death file, and moves out of the area were determined
through the National Change of Address System and by
follow-up letters and telephone calls.
Statistical analysis
Comparison of baseline covariates was conducted by
using analysis of variance or Kruskal-Wallis or χ2 test as
appropriate. Multivariable-adjusted hazards and 95% confi-
dence intervals of the incidence of pancreatic cancer accord-
ing to fish or LC-PUFA intake were estimated by using Cox
proportional hazards models. To increase statistical power,
we used tertiles rather than quartiles or quintiles of each ex-
posure variable in Cox models with the lowest tertile as the
reference group. The proportional hazards assumption was
assessed by graphical methods and the “Supremum test”
(25). Risk factors for pancreatic cancer in previous studies
were evaluated for confounding and were included as covar-
iates if the risk factor was determined to be a common
cause of fish or LC-PUFA intake and pancreatic cancer risk
or if inclusion of the factor in statistical models affected the
parameter estimate by at least 10%. In model 1, we consid-
ered 4 demographic variables as confounders, including
age, gender, ethnicity, and educational levels. In model 2,
we further included major lifestyle variables and other
dietary and nondietary confounders, including body mass
index, physical activity, smoking status, alcohol con-
sumption, family history of pancreatic cancer, diabetes mel-
litus, nonsteroidal antiinflammatory drug (NSAID) use, and
dietary intakes of fruits, vegetables, dairy products, red/
processed meat, and total calories. In addition, individual
types of fish were mutually adjusted for other types of fish
intake. We examined total LC-PUFAs (EPA + DHA+DPA)
and EPA and DHA separately. Because DPA is an interme-
diary between EPA and DHA and the amount of DPA is
relatively small, we did not examine DPA as a separate ex-
posure. To further ensure that the comparison groups are
comparable with multivariable adjustment, we calculated
and adjusted for propensity scores instead of multiple covar-
iates (26, 27). Furthermore, to determine if the missing data
in covariates substantially biased our results, we performed
a multiple imputation procedure using a regression switch-
ing approach (multiple imputation by chained equations) as-
suming that data were missing at random (28). P values for
linear trend were computed by using the continuous vari-
ables while excluding values above the 98th percentile for
each exposure in multivariable-adjusted models.
All analyses were performed by using SAS, version 9.2,
software (SAS Institute, Inc., Cary, North Carolina). All
P values reported are 2 sided, and those that were less than
0.05 were considered statistically significant.
RESULTS
During an average follow-up of 6.8 years, 151 new cases
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Table 1 gives demographic and other baseline characteris-
tics of the study population by total LC-PUFA intake.
Compared with those in the lowest tertile of LC-PUFA
intake, participants in the highest tertile tended to be male;
former or never smokers; college graduates; physically
active; NSAID users; and consumers of greater amounts of
fruits, vegetables, red or processed meats, alcohol, and
calories. Although statistically different, there were no ap-
preciable differences in age and body mass index across
LC-PUFA intake groups.
Table 2 shows results of the associations between LC-
PUFA intake and pancreatic cancer risk. LC-PUFA intake
was inversely associated with incident pancreatic cancer.
Comparing the highest tertile of LC-PUFA intake with the
lowest tertile, we found that the multivariable-adjusted
hazard ratio was 0.62 (95% CI: 0.40, 0.98) (Plinear
trend = 0.08). The inverse association was stronger for the
DHA intake (hazard ratio (HR) = 0.56, 95% CI: 0.35, 0.91)
(Ptrend = 0.04) than for the EPA intake (HR = 0.69, 95% CI:
0.44, 1.08) (Ptrend = 0.34).
Table 3 presents findings on fish consumption and pan-
creatic cancer incidence. Relative to the lowest tertile, par-
ticipants who consumed the highest tertile of nonfried fish
had a statistically significant reduction in pancreatic cancer
incidence (HR = 0.55, 95% CI: 0.34, 0.88) (Ptrend = 0.045).
No statistically significant associations were found with
total fish, shellfish, and fried fish.
At baseline, we excluded approximately 14% of partici-
pants from the VITAL cohort mainly because of missing
data, but no significant differences were observed in major
demographic and lifestyle variables between the study pop-
ulation and the original VITAL cohort (data not shown). In
addition, when we used the multiple imputation procedure
for all missing values in a sensitivity analysis, the results
remained and the hazard ratio was 0.54 (95% CI: 0.33,
0.89) for nonfried fish consumption and 0.64 (95% CI:
0.41, 0.995) for LC-PUFA intake comparing the highest
tertile of exposure with the lowest. Also, in the main analy-
ses, we focused on participants who had data available on
both fish consumption and fish oil supplement use, so that
we excluded some participants who had data on fish oil
supplement use only. When we included those participants
in the sensitivity analysis of examining LC-PUFA intake
and pancreatic cancer risk, the results were essentially the
same (data not shown). Approximately 10% of participants
used fish oil supplements. To explore the impact of fish oil
supplementation, we adjusted for fish oil supplement use
and analyzed data in supplement nonusers only. Our find-
ings were consistent (data not shown). In addition, consid-
ering that the LC-PUFA contents are different in dark and
white meat nonfried fish, we examined these 2 types of fish
separately; no appreciable differences were found between
these 2 fish groups (data not shown). Moreover, the ob-
served associations remained after controlling for propensi-
ty scores, which were derived from the same covariates in
the multivariable analyses. For example, the hazard ratio
was 0.52 (95% CI: 0.32, 0.84) for nonfried fish consump-
tion and 0.59 (95% CI: 0.37, 0.94) for LC-PUFA intake
when the highest tertile of exposure was compared with the
lowest.
DISCUSSION
In this prospective cohort study, we found that intakes of
LC-PUFAs, particularly DHA, were inversely related to in-
cidence of pancreatic cancer. The association between fish
consumption and incidence of pancreatic cancer varied de-
pending on the type of fish consumed. Higher intake of
nonfried fish, but not fried fish or shellfish, was associated
with lower incidence of pancreatic cancer.
Seven prospective cohort studies have reported results on
the association of fish intake with incidence of or mortality
from pancreatic cancer (6–12). None of the previous
studies found a significant association, and the combined
association between fish consumption and pancreatic
cancer was also statistically nonsignificant. Of note, these
studies were designed to study either meat consumption or
dietary fat intake but not specifically fish or LC-PUFAs.
Thus, most of these studies focused on total fish rather than
types of fish or preparation methods. The variation of po-
tential health impacts of fish consumption from different
cooking methods has not been well studied, but it has been
suggested that broiled and baked fish, but not fried fish and
fish sandwiches, may provide a cardioprotective benefit
(29, 30). Although more research is needed, these studies
on cardiovascular outcomes indicate that the potential
effects of fish intake on human health may vary by prepara-
tion methods. Laboratory studies suggest that frying may
modify the lipid profile through a decrease in LC-PUFA
content (14). Deep frying (e.g., fried fast foods) may also
cause the presence of trans-fatty acids and lipid oxidation
products that may consequently increase the risk of carcino-
genesis (31–33) by promoting systemic inflammation (34,
35) and oxidant stress (36, 37). In addition, frying may
generate unexpected chemicals such as heterocyclic amines
and benzo(a)pyrene (15), and these chemicals alone and in
interaction with other factors may contribute to the devel-
opment of pancreatic cancer (16, 17).
Consistent with prior cohort studies, the present study
found little evidence for a significant association between
total fish consumption and incidence of pancreatic cancer.
However, a significant inverse association of nonfried fish
intake with incident pancreatic cancer was observed in our
study. Interestingly, we found that shellfish intake was
modestly related to the elevated incidence of pancreatic
cancer, although the association was statistically nonsignifi-
cant. It has been recently hypothesized that shellfish con-
sumption may be a risk factor for colorectal and other
digestive system cancers because shellfish accumulates di-
arrheic shellfish poisoning toxins such as okadaic acid (38).
Moreover, a positive association between shellfish con-
sumption and risk of colorectal cancer has been reported in
a large cohort study (39). Hence, any potential pancreatic
cancer risk reduction associated with nonfried fish is likely
to be substantially attenuated or masked by combining non-
fried fish with fried fish and/or shellfish.
In addition, 3 prior cohort studies examined the associa-
tion between LC-PUFA intake and pancreatic cancer risk,
and 2 studies found no significant association with LC-
PUFAs and pancreatic cancer (7, 12), while one study re-
ported a significant positive association between DHA and
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pancreatic cancer (40). Nevertheless, the pooled association
between LC-PUFAs and pancreatic cancer was nonsignifi-
cant (13). Of note, none of these 3 studies specified if fish
oil supplement use was accounted for in total LC-PUFA
intake. The generally consistent associations between fish
and LC-PUFAs in relation to pancreatic cancer risk may
reflect that LC-PUFA intake assessed by a diet measure-
ment instrument is more likely a surrogate marker of fish
consumption given that LC-PUFA intake is calculated on
the basis of the frequency of fish consumption. Thus, paral-
lel associations between fish and dietary LC-PUFA intake
with health outcomes are likely to be observed.
In the present study, we also found an inverse association
between total LC-PUFA intake and pancreatic cancer inci-
dence. Our findings are biologically plausible. Studies
suggest that a number of cytokines, transcription factors,
and proinflammatory enzymes are associated with pancreat-
ic cancer; for example, tumor necrosis factor-alpha and in-
terleukin-6 are increased in pancreatic cancer (41, 42). In
addition, the expression of cyclooxygenase-2, an inducible
isoform activated by cytokines and growth factors that
produce predominately proinflammatory prostaglandins
(43), is increased in pancreatic cancer, which further sug-
gests a link between the inflammatory and oncogenic path-
ways (44). In addition, evidence from both experimental
and observational studies suggests that LC-PUFAs exhibit
antiinflammatory properties by competitively inhibiting the
arachidonic aid (45–47). Thus, higher intake of LC-PUFAs
may provide beneficial effects on pancreatic cancer devel-
opment by reducing inflammation levels.
Further, we found that DHA was superior to EPA in rela-
tion to pancreatic cancer risk reduction. Laboratory studies
indicated that DHA is more readily incorporated into tissue
phospholipids than EPA and thus should be more effective
in decreasing inflammation (48–50). Moreover, human
studies have shown that a high concentration of DHA, but
not EPA, in serum phospholipids and plasma may reduce the
incidence of inflammatory-related chronic diseases (51, 52).
Several other strengths of our study need to be highlight-
ed in addition to the prospective study design and the large









Model 1b Model 2c
HR 95% CI HR 95% CI
LC-PUFA
Tertile 1 <0.123 22,206 68 1 Referent 1 Referent
Tertile 2 0.123–0.286 22,205 44 0.66 0.45, 0.97 0.74 0.50, 1.09
Tertile 3 ≥0.287 22,205 39 0.59 0.39, 0.88 0.62 0.40, 0.98
Continuous 0.44 0.20, 1.01 0.45 0.18, 1.10
Ptrendd 0.052 0.08
EPA
Tertile 1 <0.037 22,206 64 1 Referent 1 Referent
Tertile 2 0.037–0.089 22,205 46 0.73 0.50, 1.08 0.82 0.55, 1.22
Tertile 3 ≥0.090 22,205 41 0.65 0.44, 0.98 0.69 0.44, 1.08
Continuous 0.31 0.04, 2.25 0.36 0.04, 2.96
Ptrendd 0.25 0.34
DHA
Tertile 1 <0.072 22,204 63 1 Referent 1 Referent
Tertile 2 0.072–0.169 22,207 55 0.89 0.62, 1.28 0.99 0.68, 1.44
Tertile 3 ≥0.170 22,205 33 0.53 0.35, 0.83 0.56 0.35, 0.91
Continuous 0.19 0.04, 0.83 0.18 0.03, 0.92
Ptrendd 0.03 0.04
Abbreviations: CI, confidence interval; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HR, hazard ratio; LC-PUFA, long-chain (n-
3) polyunsaturated fatty acid; MET, metabolic equivalent; NSAID, nonsteroidal antiinflammatory drug; VITAL, VITamins And Lifestyle.
a All models were constructed by using Cox proportional hazards regression analysis.
b Model 1: adjusted for age (time variable), gender, ethnicity (white, nonwhite), and education (high school graduate or less, some college,
college or advanced degree).
c Model 2: additionally adjusted for body mass index (<25, 25–29, ≥30 kg/m2), physical activity (0, tertile of MET-hours/week), smoking
status (never smokers, former smokers quit >10 years, former smokers quit ≤10 years, and current smokers), alcohol consumption (tertile),
diabetes mellitus (yes or no), family history of pancreatic cancer (yes or no), NSAID use (yes or no), and dietary intakes (tertile) of fruits,
vegetables, dairy products, red/processed meat, and calories.
d Plinear trend was examined by using the continuous variable of exposure.
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cohort study population. Detailed information on fish con-
sumption measured by a validated food frequency question-
naire enables us to specify types of fish in the analysis,
which may be crucial in studies of fish and chronic diseas-
es. Also, we used a comprehensive instrument that captured
long-term use of fish oil supplements so that we are able to
more accurately estimate total LC-PUFA exposure. This is
especially important because fish oil supplementation is
common now in the United States. The reliability and va-
lidity of the measures of 10-year average use have been
evaluated (53). Notably, the assessment of average intake
during the 10 years before baseline allowed us to more
closely investigate supplement use over the relevant period
of cancer development. In addition, pancreatic cancer cases
were ascertained by using a comprehensive linkage system
with the SEER registry, which we have estimated to be
almost 100% complete, suggesting that the possibility of
case misclassification should be small.
A few limitations of this study should also be considered.
As with other observational studies, the possibility of un-
controlled or residual confounding cannot be completely
excluded even though we did extensive adjustment in the
analysis. Second, despite the large cohort study population,
our capability of investigating potential effect modifiers
(e.g., gender, NSAID use) is limited by the relatively small
number of incident cases. Third, measurement error of
diet assessment by food frequency questionnaire is inevita-
ble. However, because of the prospective design, the








Model 1b Model 2c
HR 95% CI HR 95% CI
Total fish
Tertile 1 <1.225 22,218 58 1 Referent 1 Referent
Tertile 2 1.225–2.283 22,223 53 0.99 0.69, 1.44 1.09 0.75–1.60
Tertile 3 ≥2.284 22,093 40 0.79 0.53, 1.18 0.83 0.54–1.28
Continuous 0.88 0.78, 1.01 0.89 0.77–1.02
Ptrendd 0.06 0.08
Nonfried fish
Tertile 1 <0.791 22,133 68 1 Referent 1 Referent
Tertile 2 0.791–1.490 22,476 44 0.66 0.45, 0.97 0.65 0.43, 0.98
Tertile 3 ≥1.491 21,840 37 0.59 0.39, 0.88 0.55 0.34, 0.88
Continuous 0.83 0.70, 0.995 0.81 0.66, 0.996
Ptrendd 0.04 0.045
Shellfish
Tertile 1 <0.175 34,004 73 1 Referent 1 Referent
Tertile 2 0.175–0.289 12,423 31 1.30 0.85, 1.99 1.42 0.90, 2.26
Tertile 3 ≥0.290 17,843 42 1.22 0.83, 1.79 1.45 0.94, 2.23
Continuous 1.07 0.77, 1.49 1.17 0.89, 1.55
Ptrendd 0.70 0.27
Fried fish
Tertile 1 <0.175 33,574 75 1 Referent 1 Referent
Tertile 2 0.175–0.289 10,940 26 1.10 0.70, 1.73 1.04 0.64, 1.69
Tertile 3 ≥0.290 20,234 46 0.93 0.64, 1.36 0.91 0.60, 1.38
Continuous 0.74 0.50, 1.11 0.71 0.45, 1.12
Ptrendd 0.14 0.14
Abbreviations: CI, confidence interval; HR, hazard ratio; NSAID, nonsteroidal antiinflammatory drug; VITAL, VITamins And Lifestyle.
a All models were constructed by using Cox proportional hazards regression analysis.
b Model 1: adjusted for age (time variable), gender, ethnicity (white, nonwhite), and education (high school graduate or less, some college,
college or advanced degree).
c Model 2: additionally adjusted for body mass index (<25, 25–29, ≥30 kg/m2), physical activity (0, tertile of nonzero values), smoking status
(never smokers, former smokers quit >10 years, former smokers quit ≤10 years, and current smokers), alcohol consumption (tertile), diabetes
mellitus (yes or no), family history of pancreatic cancer (yes or no), NSAID use (yes or no), and dietary intakes (tertile) of fruits, vegetables,
dairy products, red/processed meat, and calories; further adjusted for fried fish and shellfish (for nonfried fish) or fried fish and nonfried fish (for
shellfish), or nonfried fish and shellfish (for fried fish).
d Plinear trend was examined by using the continuous variable of exposure.
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measurement error in our study would be expected to be
nondifferential and therefore would have attenuated the
results. Fourth, diabetes cases were self-reported, which
might somehow confound our results. Finally, the great ma-
jority of participants are Caucasians so that generalizability
may be limited.
In conclusion, findings from this prospective cohort
study suggest that LC-PUFA, particularly DHA, and non-
fried fish intake may be beneficial in the primary prevention
of pancreatic cancer. Results from this study also indicate
that the potential beneficial effect of fish consumption may
depend on the types of fish consumed, with no benefits ob-
served for shellfish or fried fish. Because a randomized
placebo controlled clinical trial on fish and pancreatic
cancer may not be feasible, additional prospective studies
are needed to confirm our findings and to further investigate
the impact of different types of fish consumption and fish
preparation methods on pancreatic cancer development.
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